Drug Delivery Systems for Localized Cancer Combination Therapy.

Woodring, Ryan N; Gurysh, Elizabeth G; Bachelder, Eric M; Ainslie, Kristy M

Woodring, Ryan N; Gurysh, Elizabeth G; Bachelder, Eric M; Ainslie, Kristy M.

Afiliação

Woodring RN; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
Gurysh EG; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

ACS Appl Bio Mater ; 6(3): 934-950, 2023 03 20.

Article em En | MEDLINE | ID: mdl-36791273

Assuntos

Antineoplásicos; Neoplasias; Humanos; Sistemas de Liberação de Medicamentos; Neoplasias/tratamento farmacológico; Neoplasias/patologia; Antineoplásicos/farmacologia; Polímeros; Terapia Combinada

Palavras-chave

Cancer; Combination Therapy; Hydrogel; Localized Drug Delivery; Polymer; Scaffold; Wafer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: ACS Appl Bio Mater Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google